Hage Fadi, Hage Ali, Cervetti Manuel R, Chu Michael W A
Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Centre, London, ON, Canada.
Future Cardiol. 2024;20(7-8):409-417. doi: 10.1080/14796678.2024.2343592. Epub 2024 Jul 10.
Mitral valve repair is the ideal intervention for mitral valve disease with excellent long-term survival comparable to the age-matched general population. When the mitral valve is not repairable, mechanical prostheses may be associated with improved survival as compared with biological prostheses. Newer mechanical and biological valve prostheses have the potential to improve outcomes following mitral valve replacement in young patients. Patients presenting for mitral valve surgery after failed transcatheter mitral valve-in-valve have high rates of postoperative mortality and morbidity, exceeding those seen with reoperative mitral valve surgery, which poses issues in young patients who have a higher cumulative incidence of reintervention.
二尖瓣修复是二尖瓣疾病的理想干预措施,其长期生存率极佳,与年龄匹配的普通人群相当。当二尖瓣无法修复时,与生物瓣膜相比,机械瓣膜可能与生存率提高相关。新型机械和生物瓣膜假体有潜力改善年轻患者二尖瓣置换后的预后。经导管二尖瓣瓣中瓣手术失败后接受二尖瓣手术的患者术后死亡率和发病率很高,超过再次手术二尖瓣手术的患者,这给再次干预累积发生率较高的年轻患者带来了问题。